143 related articles for article (PubMed ID: 10620310)
1. Structural studies of a crystalline insulin analog complex with protamine by atomic force microscopy.
Yip CM; Brader ML; Frank BH; DeFelippis MR; Ward MD
Biophys J; 2000 Jan; 78(1):466-73. PubMed ID: 10620310
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
[TBL] [Abstract][Full Text] [Related]
3. Atomic force microscopy of crystalline insulins: the influence of sequence variation on crystallization and interfacial structure.
Yip CM; Brader ML; DeFelippis MR; Ward MD
Biophys J; 1998 May; 74(5):2199-209. PubMed ID: 9591647
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of insulin NPH formulations.
Norrman M; Hubálek F; Schluckebier G
Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
[TBL] [Abstract][Full Text] [Related]
5. Structural and morphological characterization of ultralente insulin crystals by atomic force microscopy: evidence of hydrophobically driven assembly.
Yip CM; DeFelippis MR; Frank BH; Brader ML; Ward MD
Biophys J; 1998 Sep; 75(3):1172-9. PubMed ID: 9726919
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
[TBL] [Abstract][Full Text] [Related]
7. Reversible adsorption of soluble hexameric insulin onto the surface of insulin crystals cocrystallized with protamine: an electrostatic interaction.
Dodd SW; Havel HA; Kovach PM; Lakshminarayan C; Redmon MP; Sargeant CM; Sullivan GR; Beals JM
Pharm Res; 1995 Jan; 12(1):60-8. PubMed ID: 7724489
[TBL] [Abstract][Full Text] [Related]
8. Atomic force microscopy of insulin single crystals: direct visualization of molecules and crystal growth.
Yip CM; Ward MD
Biophys J; 1996 Aug; 71(2):1071-8. PubMed ID: 8842243
[TBL] [Abstract][Full Text] [Related]
9. A novel protein cross-linking reaction in stressed Neutral Protamine Hagedorn formulations of insulin.
Beavis RC; Kneirman MD; Sharknas D; Heady MA; Frank BH; DeFelippis MR
J Pharm Sci; 1999 Mar; 88(3):331-6. PubMed ID: 10052992
[TBL] [Abstract][Full Text] [Related]
10. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
Yanagisawa K
Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
[TBL] [Abstract][Full Text] [Related]
11. A direct comparison of the pharmacodynamic properties of insulin detemir and neutral protamine lispro insulin in patients with type 1 diabetes.
Korsatko S; Glettler K; Olsen KJ; Wutte A; Bock G; Koehler G; Mader JK; Semlitsch B; Pieber TR
Diabetes Obes Metab; 2013 Mar; 15(3):241-5. PubMed ID: 23013357
[TBL] [Abstract][Full Text] [Related]
12. [Insulin Lispro (Lys B28, Pro B29) treatment in adolescents and young people with type 1 diabetes].
Tuset Castellano MJ; Martínez Badás I; Alonso Blanco M; Barrio Castellanos R
An Esp Pediatr; 2000 Apr; 52(4):334-8. PubMed ID: 11003924
[TBL] [Abstract][Full Text] [Related]
13. Stability of U-10 and U-50 dilutions of insulin lispro.
Stickelmeyer MP; Graf CJ; Frank BH; Ballard RL; Storms SM
Diabetes Technol Ther; 2000; 2(1):61-6. PubMed ID: 11467323
[TBL] [Abstract][Full Text] [Related]
14. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
Levy JH; Zaidan JR; Faraj B
Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
18. Diabetic pregnancy outcomes in mothers treated with basal insulin lispro protamine suspension or NPH insulin: a multicenter retrospective Italian study.
Dalfrà MG; Soldato A; Moghetti P; Lombardi S; Vinci C; De Cata AP; Romanelli T; Bonomo M; Sciacca L; Tata F; Ragazzi E; Filippi A; Burlina S; Lapolla A
J Matern Fetal Neonatal Med; 2016; 29(7):1061-5. PubMed ID: 25817082
[TBL] [Abstract][Full Text] [Related]
19. Comparison of incidence of acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insulin glargine.
Rhoads GG; Kosiborod M; Nesto RW; Fonseca VA; Lu SE; Zhang Q; Foody JM
Am J Cardiol; 2009 Oct; 104(7):910-6. PubMed ID: 19766755
[TBL] [Abstract][Full Text] [Related]
20. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
